Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Cell Systems|April 11, 2025
Library-based single-cell analysis of CAR signaling reveals drivers of in vivo persistenceCaleb R Perez, Andrea Garmilla, Avlant Nilsson, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Library-based single-cell analysis of CAR signaling reveals drivers of in vivo persistenceCaleb R Perez, Andrea Garmilla, Avlant Nilsson, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
True first-pass effect in basilar artery occlusions: First-pass complete reperfusion improves clinical outcome in stroke thrombectomy patientsN Abdullayev, V Maus, D Behme, et al.
Nature Communications|March 26, 2022
CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicityJulia Joung, Paul C Kirchgatterer, Ankita Singh, et al.
The New England Journal of Medicine|March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaBryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Blood Advances|February 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Cancer Immunology Research|March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignanciesGregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Nature Biotechnology|July 10, 2018
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug deliveryLi Tang, Yiran Zheng, Mariane Bandeira Melo, et al.
Blood Advances|February 24, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Pageof 22